Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
135.8 USD | +4.41% | +6.24% | -1.82% |
03:05pm | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
02:30pm | Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024 |
Chart calendar Quest Diagnostics Incorporated
Upcoming events on Quest Diagnostics Incorporated
Past events on Quest Diagnostics Incorporated
Today 08:30 am | Q1 2024 Earnings Call |
Today 06:45 am | Q1 2024 Earnings Release |
2024-04-04 | Ex-dividend day |
2024-03-13 10:15 am | Barclays Global Healthcare Conference |
2024-02-01 08:30 am | Q4 2023 Earnings Call |
2024-02-01 06:45 am | Q4 2023 Earnings Release |
2024-01-15 | Ex-dividend day |
2024-01-09 06:45 pm | JPMorgan Healthcare Conference |
2023-10-24 08:30 am | Q3 2023 Earnings Call |
2023-10-24 06:45 am | Q3 2023 Earnings Release |
2023-10-04 | Ex-dividend day |
2023-09-13 02:00 pm | Baird Global Healthcare Conference |
2023-07-26 08:30 am | Q2 2023 Earnings Call |
2023-07-26 06:45 am | Q2 2023 Earnings Release |
2023-07-09 | Ex-dividend day |
2023-06-08 02:30 pm | Jefferies Global Healthcare Conference |
2023-06-06 04:20 pm | William Blair Growth Stock Conference |
2023-05-22 | National Drug & Alcohol Screening Association Conference |
2023-05-17 10:30 am | Annual General Meeting |
2023-04-27 08:30 am | Q1 2023 Earnings Call |
Past dividends on Quest Diagnostics Incorporated
2024-04-04 | Quarterly 0.75 USD |
2024-01-15 | Quarterly 0.71 USD |
2023-10-04 | Quarterly 0.71 USD |
2023-07-09 | Quarterly 0.71 USD |
2023-04-05 | Quarterly 0.71 USD |
2023-01-16 | Quarterly 0.66 USD |
2022-10-02 | Quarterly 0.66 USD |
2022-07-04 | Quarterly 0.66 USD |
2022-04-04 | Quarterly 0.66 USD |
2022-01-17 | Quarterly 0.62 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7 726 7 717 0.11% | 9 437 9 358 0.84% | 10 788 10 697 0.85% | 9 883 9 828 0.56% | 9 252 9 214 0.41% | 9 398 |
EBITDA Million USD | Released Forecast Spread | 1 549 1 547 0.14% | 2 468 2 369 4.19% | 2 870 2 864 0.2% | 2 059 2 081 -1.04% | 1 788 1 860 -3.87% | 1 876 |
EBIT Million USD | Released Forecast Spread | 1 220 1 199 1.79% | 2 107 1 960 7.48% | 2 462 2 417 1.87% | 1 742 1 753 -0.61% | 1 457 1 494 -2.44% | 1 516 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 076 964 11.6% | 1 884 1 793 5.09% | 2 599 2 514 3.4% | 1 235 1 455 -15.14% | 1 130 1 174 -3.74% | 1 197 |
Net income Million USD | Released Forecast Spread | 858 773 10.97% | 1 431 1 382 3.52% | 1 995 1 869 6.75% | 946 1 054 -10.28% | 854 876 -2.56% | 897 |
EPS USD | Released Forecast Spread | 6,28 5,61 11.96% | 10,5 10,3 1.73% | 15,6 15,0 3.92% | 7,97 8,76 -8.97% | 7,49 7,67 -2.38% | 7,79 |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 744 2 665 2.97% | 2 611 2 639 -1.05% | 2 453 2 336 5.02% | 2 486 2 343 6.09% | 2 333 2 258 3.31% | 2 331 2 203 5.83% | 2 338 2 258 3.55% | 2 295 2 268 1.19% | 2 288 2 251 1.63% | 2 287 | 2 394 | 2 371 | 2 350 | 2 365 |
EBITDA Million USD | Released Forecast Spread | 659 672 -1.9% | 660 622 6.11% | 515 483 6.63% | 504 470 7.13% | 407 425 -4.31% | 431 413 4.3% | 473 466 1.42% | 464 464 -0.05% | 420 479 -12.28% | 415 | 492 | 486 | 467 | 443 |
EBIT Million USD | Released Forecast Spread | 553 587 -5.81% | 554 530 4.46% | 435 391 11.17% | 423 394 7.41% | 330 352 -6.19% | 350 335 4.54% | 389 381 2.18% | 380 382 -0.43% | 338 373 -9.26% | 331 | 407 | 400 | 370 | 357 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 502 546 -7.97% | 452 472 -4.24% | 323 353 -8.46% | 351 345 1.73% | 109 324 -66.32% | 277 337 -17.9% | 317 342 -7.42% | 299 333 -10.21% | 237 306 -22.55% | 255 | 328 | 321 | 291 | 271 |
Net income Million USD | Released Forecast Spread | 390 375 4.1% | 355 363 -2.14% | 234 250 -6.4% | 256 236 8.51% | 101 195 -48.16% | 202 186 8.48% | 235 229 2.63% | 225 225 0.21% | 192 210 -8.62% | 186 | 241 | 239 | 217 | 197 |
EPS USD | Released Forecast Spread | 3,12 3,06 1.81% | 2,92 2,90 0.85% | 1,96 2,04 -3.72% | 2,17 1,96 10.85% | 0,87 1,63 -46.71% | 1,78 1,60 11.46% | 2,05 2,00 2.64% | 1,96 1,94 0.84% | 1,70 1,85 -7.9% | 1,60 | 2,10 | 2,08 | 1,90 | 1,78 |
Announcement Date | 03/02/22 | 21/04/22 | 21/07/22 | 20/10/22 | 02/02/23 | 27/04/23 | 26/07/23 | 24/10/23 | 01/02/24 | - | - | - | - | - |
Past sector events for Quest Diagnostics Incorporated
Today 07:00 am | OPTION CARE HEALTH, INC.: Q1 2024 Earnings Release |
Today 06:45 am | QUEST DIAGNOSTICS INCORPORATED: Q1 2024 Earnings Release |
2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q1 2024 Earnings Release |
2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q4 2023 Earnings Release |
2024-04-17 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q4 2023 Earnings Release |
2024-04-08 04:30 pm | SUMMERSET GROUP HOLDINGS LIMITED: Q1 2024 Sales and Revenue Release |
2024-04-02 | PT FAMON AWAL BROS SEDAYA TBK: Q4 2023 Earnings Release (Projected) |
2024-03-28 04:00 am | RHÖN-KLINIKUM AG: Q4 2023 Earnings Release |
2024-03-28 01:06 am | FUTURE CARE TRADING CO.: Q4 2023 Earnings Release |
2024-03-26 | DIAGNOSTICOS DA AMÉRICA S.A.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DGX Stock
- Calendar Quest Diagnostics Incorporated